XEGLYZE

Peak

abametapir

NDATOPICALLOTION
Approved
Jul 2020
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Dec 17, 2034
106 months away
Patent Expiry
Dec 17, 2034

Patent Records (2)

Patent #ExpiryTypeUse Code
7812163
Oct 28, 2026
Product
U-2863
10292389
Dec 17, 2034
Product
U-2863
External Resources
FDA Drugs@FDA
FDA approval history